Daniel Parker

Technology Investor
Seeking the next 10x story
AI | Space | Robotics
Ideas over noise.

[Daniel Parker @DanParkerMacro]

Monday To-Do List:
Does trading volume confirm this trend?
Can the Nasdaq Index maintain its strength?
Are AI-related stocks performing well?

Three stocks I’m watching: $LITE, $COHR, and $PLTR
Follow my account to receive my latest watchlist before the market opens.

#LITE #COHR

[Daniel Parker @DanParkerMacro]

Here are my two stock picks for Monday: $PLTR and $ORCL

$PLTR remains one of the most closely watched AI software companies, while $ORCL has significant exposure to demand for cloud infrastructure and AI-related data centers.
#PLTR #ORCL #EnterpriseAI #CloudComputing #AISoftware

[Daniel Parker @DanParkerMacro]

$MASS: Bullish Thesis
Target price roughly $12–$14.
There is upside potential, but it hinges on "continued execution" rather than the stock being "undiscovered." Short interest is significant, so expect heightened volatility.

#Stock #StockMarket #NVDA #MSFT #MU #AVGO

[Daniel Parker @DanParkerMacro]

Intel surged 7.75% after its CEO warned that global memory prices have soared 5 to 7 times due to demand for AI infrastructure, and that the shortage may persist through 2027. Nvidia rose 2.5%, while Micron, Arm, and Supermicro also posted significant gains.

#Stock #NVDA #MSFT

[Daniel Parker @DanParkerMacro]

Strongest relative strength and volume confirmation into tomorrow:
$WDAY – Enterprise software with expanding AI features.
$NOW – Workflow automation platform seeing AI-driven adoption.
#NVDA #MSFT #MU #AVGO #TSLA #AMZN #GOOGL

[Daniel Parker @DanParkerMacro]

$DCX shares surged 42.09%, reaching $0.4547.

The company is pivoting from its traditional electric vehicle (EV) business into digital asset treasury management and AI cloud services.
#Cryptocurrency #DigitalAssets #SmallCap #DCX #AI #TechStocks #MomentumTrading

[Daniel Parker @DanParkerMacro]

$DDOG has witnessed robust growth in demand for observability; its strengths lie in exceptionally high customer retention rates and an ever-expanding product portfolio.

#AI #CloudServices #Cybersecurity #SNOW #PANW #TechStocks #EnterpriseSoftware

[Daniel Parker @DanParkerMacro]

$DCX: Short-term target price: $0.55–$0.90
Look for $0.55–$0.90 in after-hours trading or upon news release.
If the price stabilizes temporarily after the reverse split and capital flows in: $1.00–$1.50.
Return to $0.26 or lower.
#Stock #NVDA #MSFT #MU #AVGO #TSLA #DCX

[Daniel Parker @DanParkerMacro]

$DDOG has witnessed robust growth in demand for observability; its strengths lie in exceptionally high customer retention rates and an ever-expanding product portfolio.

#AI #CloudServices #Cybersecurity #SNOW #PANW #TechStocks #EnterpriseSoftware

[Daniel Parker @DanParkerMacro]

$BOOK — travel and online-booking exposure.
$AM
$GOOGL — AI, advertising and cloud exposure give it multiple growth engines.
The broader market remains volatile after today’s Fed decision, but that can also create new setups for the next session.
#NVDA #MU #SNDK #AMD #AI

[Daniel Parker @DanParkerMacro]

$RYTM – A rare-disease obesity stock with strong momentum

The overall outlook remains positive. Short-term price target: $130–$145, contingent on continued growth in market demand and sustained positive progress on the program.

#Biotech #RareDiseases #Obesity #HealthcareStocks

[Daniel Parker @DanParkerMacro]

Reported Earlier, Semtech Unveils Ultra-Compact TDS2621LP With 1.6mm2 Footprint to Protect Robotics From Surge and ESD Damage

#Tesla #TSLA #SpaceX #ElonMusk #Robotics #AutonomousDriving #FutureTech

[Daniel Parker @DanParkerMacro]

@MMatters22596 Patience matters with $SOFI. 📈 The $14.88 level is definitely one to watch—if it holds, the bullish reversal setup could become much more interesting. 👀

[Daniel Parker @DanParkerMacro]

@elonmusk Tesla’s self-driving progress is definitely impressive. 🚗⚡ The bigger question is how quickly autonomous driving can scale into everyday use.

[Daniel Parker @DanParkerMacro]

Potential leading stocks to watch tomorrow:
$ORCL — Strong momentum in cloud infrastructure with consistently better-than-expected earnings;
$SNOW — Data platform business recovering, supported by rising enterprise spending;
#ORCL #Software #TechStocks #Bullish #SNOW

[Daniel Parker @DanParkerMacro]

$VEEA surged over 100% (small-cap, high volatility; mind the risks)
$BNGO rose over 30% (genetic analysis tools)
$PDSB rose over 50% (biotech catalyst)

#Biotech #StockMarket #PennyStocks #BullMarket #AI #Healthcare #Volatility

[Daniel Parker @DanParkerMacro]

$EDIT: Currently trading at 2.74; for the short term, look for a move to the 3.2–3.6 range. Once human safety is successfully demonstrated, the market will re-rate the stock as a "cardiovascular gene therapy" company rather than just another CRISPR shell
#NVDA #PLTR #TSLA #EDIT

[Daniel Parker @DanParkerMacro]

$AMZN $ABNB $DIS.
Advantage: ads + marketplace + travel + IP. Discretionary names can snap back if the Fed day is “hike and done” instead of “hike and panic.”
Which brand do you actually spend money on this month?
#EcommerceGiant #TravelRebound #StreamingWars

[Daniel Parker @DanParkerMacro]

From Recommendation to a Strong Close.
$TLX closed at 16.34, up +0.67 (+4.28%). The story in the radiopharmaceutical sector continues to unfold smoothly. Want to be part of the next chapter? Follow me and join the group.
#TLX #Telix #Radiopharmaceuticals #BiotechStory

[Daniel Parker @DanParkerMacro]

$TLX: Full-year 2026 revenue guidance of $9.5–9.7 billion, expected to land at the high end
Regulatory progress for Pixclara (brain cancer imaging) and Zircaix (kidney cancer imaging)
Phase 3 trials advancing for the therapeutic pipeline (prostate cancer, etc.)
#NVDA #TSLA #AMD

[Daniel Parker @DanParkerMacro]

$BNC surged to 5.20, up +0.40 (+8.33%). Strengths: Demand for infrastructure and machinery provides strong support.

#BNC #CEAIndustries #Manufacturing #Machinery #InfrastructureStocks #SmallCapNews

[Daniel Parker @DanParkerMacro]

$TLX: Full-year 2026 revenue guidance of $9.5–9.7 billion, expected to land at the high end
Regulatory progress for Pixclara (brain cancer imaging) and Zircaix (kidney cancer imaging)
Phase 3 trials advancing for the therapeutic pipeline (prostate cancer, etc.)
#NVDA #TSLA #AMD

[Daniel Parker @DanParkerMacro]

$TLX: Full-year 2026 revenue guidance of $9.5–9.7 billion, expected to land at the high end
Regulatory progress for Pixclara (brain cancer imaging) and Zircaix (kidney cancer imaging)
Phase 3 trials advancing for the therapeutic pipeline (prostate cancer, etc.)
#NVDA #TSLA #AMD